www.fdanews.com/articles/123221-synta-pharma-initiates-phase-ii-clinical-study-of-sta-9090

Synta Pharma Initiates Phase II Clinical Study of STA-9090

December 25, 2009

Synta Pharmaceuticals Corp said it is initiating a Phase 2 clinical study of STA-9090 in patients with advanced gastrointestinal stromal tumors, or GIST.
RTTNews